Canadian Cancer Trials Group

Dr Normand Laperriere, Canadian Cancer Trials Group, University Health Network, Princess Margaret Cancer Centre; Dr Christopher O’Callaghan, Canadian Cancer Trials Group, Queen’s University; Dr James Perry, Canadian Cancer Trials Group, Sunnybrook Health Sciences Centre

Canadian Cancer Trials Group researcher Dr Christopher O’Callaghan
The Canadian Cancer Trials Group is improving glioblastoma survival in the elderly.

A pivotal clinical trial led by the Society-supported Canadian Cancer Trials Group found that some older patients with glioblastoma who received chemotherapy with a short course of radiation lived about twice as long as those who only got radiation. Glioblastoma is currently an incurable form of brain cancer. This research is changing how glioblastoma is treated in elderly patients around the world.

Learn more about the impact of our research, supported by your donations.

Reference: ASCO Annual Meeting, June 2016

Pictured: Canadian Cancer Trials Group researcher Dr Christopher O’Callaghan